Results 211 to 220 of about 6,020,192 (375)

Measures of tonic and phasic activity of the locus coeruleus—norepinephrine system in children with autism spectrum disorder: An event‐related potential and pupillometry study

Autism Research, Volume 15, Issue 12, Page 2250-2264, December 2022., 2022
Abstract A growing body of research suggests that locus coeruleus‐norepinephrine (LC‐NE) system may function differently in individuals with autism spectrum disorder (ASD). Understanding the dynamics of both tonic (resting pupil diameter) and phasic (pupil dilation response [PDR] and event‐related potential [ERP]) indices may provide meaningful ...
Yesol Kim, Girija Kadlaskar, Rebecca McNally Keehn, Brandon Keehn   +3 more
wiley   +1 more source

Multiple Sclerosis: A Virus-Induced Gliopathy? [PDF]

Neurol Neuroimmunol Neuroinflamm
Sabatino JJ, Steinman L.
europepmc   +1 more source

Association of maternal autoimmune disease and early childhood infections with offspring autism spectrum disorder: A population‐based cohort study

Autism Research, Volume 15, Issue 12, Page 2371-2380, December 2022., 2022
Abstract The aim of this study was to examine potential synergistic effects between maternal autoimmune disease and early childhood infections and their association with autism spectrum disorder (ASD) in offspring. Both exposures have been associated with increased risk of ASD in previous studies, but potential synergistic effects remain underexplored.
Timothy C. Nielsen, Natasha Nassar, Antonia W. Shand, Hannah F. Jones, Velda X. Han, Shrujna Patel, Adam J. Guastella, Russell C. Dale, Samantha J. Lain   +8 more
wiley   +1 more source

Natural killer cells in multiple sclerosis: foe or friends? [PDF]

Front Cell Neurosci
Aghaee F, Abedinpour M, Anvari S, Saberi A, Fallah A, Bakhshi A.   +5 more
europepmc   +1 more source

Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease [PDF]

, 1965
J. N. Cumings, R. C. Shortman, THOMAS R. SKRBIC   +2 more
openalex   +1 more source

Systematic review of antitumour efficacy and mechanism of metformin activity in prostate cancer models

BJUI Compass, Volume 4, Issue 1, Page 44-58, January 2023., 2023
Abstract Metformin, the first line pharmacotherapy for type 2 diabetes has demonstrated favourable effects in prostate cancer (PCa) across a range of studies evaluating PCa patient outcomes amongst metformin users. However, a lack of rigorously conducted prospective studies has stalled clinical use in this setting.
Nan Fang Wang, Toni Rose Jue, Jeff Holst, Jennifer H. Gunter   +3 more
wiley   +1 more source

Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosis. [PDF]

Mult Scler J Exp Transl Clin
Sandesjö F, Alping P, Fink K, Wickström R, Piehl F, Frisell T, McKay KA.   +6 more
europepmc   +1 more source

Infective Agents and Multiple Sclerosis [PDF]

, 1965
Constance A. C. Ross, J. A. R. Lenman, Charlotte Rutter   +2 more
openalex   +1 more source

Self‐Administered Taste Testing Without Water: Normative Data for the 53‐Item Waterless Empirical Taste Test (WETT)

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background According to the National Health and Nutrition Examination Survey (NHANES), more than 20 million Americans suffer from chronic taste problems. Unfortunately, quantitative testing is rarely performed, self‐reports are inaccurate, and “taste” is often confused with olfaction‐dependent flavors.
Richard L. Doty, Ryan Sharetts, Shima T. Moein   +2 more
wiley   +1 more source

Advances in Multiple Sclerosis. [PDF]

Biomedicines
Rivera VM.
europepmc   +1 more source